UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

Nature communications, 2020-08, Vol.11 (1), p.4279-4279, Article 4279

2020

Link zum Volltext

Verfügbarkeit prüfen

MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway

Cancer research (Chicago, Ill.), 2017-08, Vol.77 (16), p.4414-4425

2017

Link zum Volltext

Verfügbarkeit prüfen

Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment

Journal of clinical oncology, 2022-03, Vol.40 (8), p.876-883

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of Potent Glucagon-like Peptide-1 Agonists with High Enzyme Stability via Introduction of Multiple Lactam Bridges

Journal of medicinal chemistry, 2010-09, Vol.53 (17), p.6412-6420

2010

Link zum Volltext

Verfügbarkeit prüfen

A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer

JNCI : Journal of the National Cancer Institute, 2019-04, Vol.111 (4), p.372-379

2019

Link zum Volltext

Verfügbarkeit prüfen

A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer

Cancers, 2021-02, Vol.13 (4), p.913

2021

Link zum Volltext

Verfügbarkeit prüfen

Plasma Based Protein Signatures Associated with Small Cell Lung Cancer

Cancers, 2021-08, Vol.13 (16), p.3972

2021

Link zum Volltext

Verfügbarkeit prüfen

Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Frontiers in artificial intelligence, 2022-08, Vol.5, p.876100-876100

2022

Link zum Volltext

Verfügbarkeit prüfen

Search for α-helical propensity in the receptor-bound conformation of glucagon-like peptide-1

Bioorganic & medicinal chemistry, 2008-12, Vol.16 (23), p.10106-10112

2008

Link zum Volltext

Verfügbarkeit prüfen

PET of Insulinoma Using 18F-FBEM-EM3106B, a New GLP-1 Analogue

Molecular pharmaceutics, 2011-10, Vol.8 (5), p.1775-1782

2011

Link zum Volltext

Verfügbarkeit prüfen

MP32-14 ASSOCIATION OF BASELINE PLASMA CAFFEINE LEVELS AND RELATED METABOLITES WITH TIME TO GRADE GROUP PROGRESSION IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Link zum Volltext

Verfügbarkeit prüfen

Validation of 4-marker protein panel for the early detection of lung cancer using PLCO samples

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9024-9024

2020

Link zum Volltext

Verfügbarkeit prüfen

Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer

JNCI : Journal of the National Cancer Institute, 2020-06, Vol.112 (6), p.607-616

2020

Link zum Volltext

Verfügbarkeit prüfen

A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses

Clinical cancer research, 2022-11, Vol.28 (21), p.4669-4676

2022

Link zum Volltext

Verfügbarkeit prüfen

A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression

The journal of clinical endocrinology and metabolism, 2021-12, Vol.106 (12), p.e4969-e4980

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-311: Elevated kynureninase protein expression is associated with KEAP1 mutant non-small cell lung cancer and is predictive of poor overall survival

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.LB-311-LB-311

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2503: Metabolomics identifies a caveolin-1-associated plasma glycosphingolipid and sphingomyelin signature that differentiates aggressive from indolent prostate cancer in an active surveillance cohort

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2503-2503

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1447: Aberrant tryptophan catabolism marked by high kynureninase expression contributes to immunosuppression and poor outcome in lung adenocarcinoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1447-1447

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3170: MCAM modulates small cell lung cancer chemoresistance via PI3k/Akt/Sox2 signaling pathway

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3170-3170

2017

Link zum Volltext

Verfügbarkeit prüfen

A Novel Mechanism of Chemoresistance in Small Cell Lung Cancer mediated by MCAM via PI3K/AKT/SOX2 Signaling Pathway

Cancer research (Chicago, Ill.), 2017-06, Vol.77 (16), p.4414-4425

2017

Link zum Volltext

Verfügbarkeit prüfen

A blood-based metabolomic signature predictive of risk for pancreatic cancer

Cell reports. Medicine, 2023-09, Vol.4 (9), p.101194-101194, Article 101194

2023

Link zum Volltext

Verfügbarkeit prüfen

Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial

EBioMedicine, 2023-12, Vol.98, p.104873-104873, Article 104873

2023

Link zum Volltext

Verfügbarkeit prüfen

Seeking for α-Helical Propensity in a Receptor-Bound Conformation of Glucagon-Like Peptide-1

Advances in experimental medicine and biology, 2009, Vol.611, p.289-290

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(30)
Dissertationen
(2)

Sprache

Englisch
(32)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(16)
Humans
(14)
Oncology
(9)
Metabolomics
(6)
Female
(5)
Glucagon-Like Peptide-1 Receptor
(5)
Mass Spectrometry
(5)
Animals
(4)
Glucagon-Like Peptide 1 - Chemistry
(4)
Metabolites
(4)
Receptors, Glucagon - Agonists
(4)
Tumors
(4)
Accountability
(3)
Biomarkers
(3)
Circular Dichroism
(3)
Gene Expression
(3)
Glucagon-Like Peptide 1 - Analogs & Derivatives
(3)
Lung Cancer
(3)
Male
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway

Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment

Development of Potent Glucagon-like Peptide-1 Agonists with High Enzyme Stability via Introduction of Multiple Lactam Bridges

A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer

Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma

A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer

Plasma Based Protein Signatures Associated with Small Cell Lung Cancer

Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Search for α-helical propensity in the receptor-bound conformation of glucagon-like peptide-1

PET of Insulinoma Using 18F-FBEM-EM3106B, a New GLP-1 Analogue

MP32-14 ASSOCIATION OF BASELINE PLASMA CAFFEINE LEVELS AND RELATED METABOLITES WITH TIME TO GRADE GROUP PROGRESSION IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE

Validation of 4-marker protein panel for the early detection of lung cancer using PLCO samples

Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer

A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses

Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome

A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression

Abstract LB-311: Elevated kynureninase protein expression is associated with KEAP1 mutant non-small cell lung cancer and is predictive of poor overall survival

Abstract 2503: Metabolomics identifies a caveolin-1-associated plasma glycosphingolipid and sphingomyelin signature that differentiates aggressive from indolent prostate cancer in an active surveillance cohort

Abstract 1447: Aberrant tryptophan catabolism marked by high kynureninase expression contributes to immunosuppression and poor outcome in lung adenocarcinoma

Abstract 3170: MCAM modulates small cell lung cancer chemoresistance via PI3k/Akt/Sox2 signaling pathway

A Novel Mechanism of Chemoresistance in Small Cell Lung Cancer mediated by MCAM via PI3K/AKT/SOX2 Signaling Pathway

A blood-based metabolomic signature predictive of risk for pancreatic cancer

Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial

Seeking for α-Helical Propensity in a Receptor-Bound Conformation of Glucagon-Like Peptide-1

Suchergebnisse filtern